A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Massachusetts General Hospital
Ossium Health, Inc.
Institute of Hematology & Blood Diseases Hospital, China
Ohio State University Comprehensive Cancer Center
Children's Hospital of Philadelphia
UNC Lineberger Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Affiliated Hospital of Qinghai University
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
City of Hope Medical Center
Medical College of Wisconsin
Children's Hospital of Philadelphia
National Institutes of Health Clinical Center (CC)
Sanguine Biosciences
Tampere University Hospital
European Institute of Oncology
Hospital Universitari Vall d'Hebron Research Institute
Boston Children's Hospital
Bellicum Pharmaceuticals
University of Nebraska
M.D. Anderson Cancer Center
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
University of Alabama at Birmingham
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Baylor College of Medicine
Malaghan Institute of Medical Research
Roswell Park Cancer Institute
University of California, San Francisco
Memorial Sloan Kettering Cancer Center
PrECOG, LLC.
CTI BioPharma
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
LEO Pharma
Indonesia University
Boston Children's Hospital
University College, London
University of Maryland, Baltimore
University of Maryland, Baltimore
Novartis
University of Arizona
Dana-Farber Cancer Institute